Braunschweig, Germany

Mahavir Singh

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf). Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahavir Singh. Retrieved from https://idiyas.com/inventor/mahavir-singh-39tdv8pc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahavir Singh: Innovator in Biotechnology

Introduction

Mahavir Singh is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of diagnostic tools for tuberculosis.

Latest Patents

One of his key inventions is a hybrid plasmid for the expression of the unfused 38 kDa antigen of Mycobacterium tuberculosis in E. coli. This patent, which he holds, is crucial for the production of a 38 kDa antigen and a protein of about 33 kDa that are useful for diagnostic purposes. He has 1 patent to his name.

Career Highlights

Throughout his career, Mahavir Singh has worked with prominent organizations in the biotechnology sector. He has been associated with Gesellschaft für Biotechnologische Forschung mbH (GBF) and Lionex GmbH, where he contributed to various research projects and innovations.

Collaborations

He has collaborated with notable colleagues, including Kenneth Nigel Timmis and Mario M Delios, enhancing the impact of his work in the field.

Conclusion

Mahavir Singh's contributions to biotechnology, particularly in the area of tuberculosis diagnostics, highlight his role as an innovative inventor. His work continues to influence the field and improve diagnostic methods for infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…